A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity
出版年份 2021 全文链接
标题
A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity
作者
关键词
-
出版物
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 3, Pages 1362-1391
出版商
American Chemical Society (ACS)
发表日期
2021-02-03
DOI
10.1021/acs.jmedchem.0c01782
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6
- (2020) Jeremy D. Osko et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo
- (2020) Ritu Ojha et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- HDAC6 inhibition promotes α-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in mice
- (2020) Cristina Picci et al. EXPERIMENTAL NEUROLOGY
- Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma
- (2020) Arghya Ray et al. ONCOGENE
- PROTACs: A novel strategy for cancer therapy
- (2020) Jing Liu et al. SEMINARS IN CANCER BIOLOGY
- Structural and in Vivo Characterization of Tubastatin A, a Widely Used Histone Deacetylase 6 Inhibitor
- (2020) Sida Shen et al. ACS Medicinal Chemistry Letters
- Indocyanine Green-Nexturastat A-PLGA Nanoparticles Combine Photothermal and Epigenetic Therapy for Melanoma
- (2020) Debbie K. Ledezma et al. Nanomaterials
- Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination
- (2020) Maria Cosenza et al. APOPTOSIS
- HDAC6 inhibitors: Translating genetic and molecular insights into a therapy for axonal CMT
- (2020) Elisabeth Rossaert et al. BRAIN RESEARCH
- Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer’s disease
- (2020) Hui-Ju Tseng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The role of HSP90 molecular chaperones in hepatocellular carcinoma
- (2020) Masoud Nouri‐Vaskeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Design, Synthesis, and Biological Evaluation of Quinazolin-4-one-Based Hydroxamic Acids as Dual PI3K/HDAC Inhibitors
- (2020) Ashish Thakur et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain
- (2020) George S. Sheppard et al. JOURNAL OF MEDICINAL CHEMISTRY
- Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab
- (2020) Estefanía García-Guerrero et al. LEUKEMIA
- Development of Selective Histone Deacetylase 6 (HDAC6) Degraders Recruiting Von Hippel–Lindau (VHL) E3 Ubiquitin Ligase
- (2020) Ka Yang et al. ACS Medicinal Chemistry Letters
- Pharmacological Inhibition of HDAC6 Attenuates NLRP3 Inflammatory Response and Protects Dopaminergic Neurons in Experimental Models of Parkinson’s Disease
- (2020) Shaoqi Yan et al. Frontiers in Aging Neuroscience
- Analysis of Dual Class I Histone Deacetylase and Lysine Demethylase Inhibitor Domatinostat (4SC-202) on Growth and Cellular and Genomic Landscape of Atypical Teratoid/Rhabdoid
- (2020) Mariah M. Hoffman et al. Cancers
- Design of Dual Inhibitors of Histone Deacetylase 6 and Heat Shock Protein 90
- (2020) Luca Pinzi et al. ACS Omega
- Screening of an Epigenetic Drug Library Identifies 4-((hydroxyamino)carbonyl)-N-(2-hydroxyethyl)-N-Phenyl-Benzeneacetamide that Reduces Melanin Synthesis by Inhibiting Tyrosinase Activity Independently of Epigenetic Mechanisms
- (2020) Hyerim Song et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
- (2020) Terence C. S. Ho et al. JOURNAL OF MEDICINAL CHEMISTRY
- A452, HDAC6-selective inhibitor synergistically enhances the anticancer activity of immunomodulatory drugs in IMiDs-resistant multiple myeloma
- (2020) Go Woon Kim et al. LEUKEMIA RESEARCH
- Characterization of a new small-molecule inhibitor of HDAC6 in glioblastoma
- (2020) Jaione Auzmendi-Iriarte et al. Cell Death & Disease
- Inhibition of HDAC6 Attenuates Diabetes-Induced Retinal Redox Imbalance and Microangiopathy
- (2020) Hossameldin Abouhish et al. Antioxidants
- Overexpression of HDAC6, but not HDAC3 and HDAC4 in the penumbra after photothrombotic stroke in the rat cerebral cortex and the neuroprotective effects of α-phenyl tropolone, HPOB, and sodium valproate
- (2020) S.V. Demyanenko et al. BRAIN RESEARCH BULLETIN
- Discovery of selective HDAC/BRD4 dual inhibitors as epigenetic probes
- (2020) Jingjing Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent update on discovery and development of Hsp90 inhibitors as senolytic agents
- (2020) Sayan Dutta Gupta et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Multicomponent Synthesis, Binding Mode, and Structure–Activity Relationship of Selective Histone Deacetylase 6 (HDAC6) Inhibitors with Bifurcated Capping Groups
- (2020) Nina Reßing et al. JOURNAL OF MEDICINAL CHEMISTRY
- Rational Design of Suprastat: A Novel Selective Histone Deacetylase 6 Inhibitor with the Ability to Potentiate Immunotherapy in Melanoma Models
- (2020) Satish Noonepalle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological Evaluation
- (2020) A. Prasanth Saraswati et al. ACS Medicinal Chemistry Letters
- Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment
- (2020) Xiaopeng Peng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Mercaptoacetamide: A promising zinc-binding group for the discovery of selective histone deacetylase 6 inhibitors
- (2020) Maurício T. Tavares et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- HDAC6 as privileged target in drug discovery: A perspective
- (2020) Sravani Pulya et al. PHARMACOLOGICAL RESEARCH
- Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigation
- (2020) Nicola Relitti et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 (HDAC6) Inhibitors
- (2019) Katharina Vögerl et al. JOURNAL OF MEDICINAL CHEMISTRY
- Developing potent PROTACs tools for selective degradation of HDAC6 protein
- (2019) Zixuan An et al. Protein & Cell
- HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics
- (2019) Andressa S. Laino et al. Journal for ImmunoTherapy of Cancer
- Tubastatin�A, an inhibitor of HDAC6, enhances temozolomide‑induced apoptosis and reverses the malignant phenotype of glioblastoma cells
- (2019) Alejandro Urdiciain et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The selective HDAC6 inhibitor Nexturastat A induces apoptosis, overcomes drug resistance and inhibits tumor growth in multiple myeloma
- (2019) Xiaoyang Sun et al. BIOSCIENCE REPORTS
- High-selective HDAC6 inhibitor promotes HDAC6 degradation following autophagy modulation and enhanced antitumor immunity in glioblastoma
- (2019) Jia-Rong Liu et al. BIOCHEMICAL PHARMACOLOGY
- Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated
- (2019) Magalie Géraldy et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone deacetylases in cardiovascular and metabolic diseases
- (2019) Rushita A. Bagchi et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- HDAC6 inhibition blocks inflammatory signaling and caspase-1 activation in LPS-induced acute lung injury
- (2019) Li Liu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Anti-metastatic activity of MPT0G211, a novel HDAC6 inhibitor, in human breast cancer cells in vitro and in vivo
- (2019) Yi-Ling Hsieh et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Design, Synthesis, and Biological Evaluation of 2,4-Imidazolinedione Derivatives as HDAC6 Isoform-Selective Inhibitors
- (2019) Tao Liang et al. ACS Medicinal Chemistry Letters
- Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells
- (2019) Tessa Knox et al. Scientific Reports
- Quantitative Proteomic Analysis Reveals the Sites Related to Acetylation and Mechanism of ACY-1215 in Acute Liver Failure Mice
- (2019) Wen-bin Zhang et al. Frontiers in Pharmacology
- HDAC-selective Inhibitor Cay10603 Has Single Anti-tumour Effect in Burkitt’s Lymphoma Cells by Impeding the Cell Cycle
- (2019) Xiu-juan Ma et al. Current Medical Science
- Multitarget Approach for the Treatment of Alzheimer’s Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles
- (2019) Obdulia Rabal et al. ACS Chemical Neuroscience
- Structure-activity relationship study of thiazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors
- (2019) Gibeom Nam et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of a New Isoxazole-3-hydroxamate-Based Histone Deacetylase 6 Inhibitor SS-208 with Antitumor Activity in Syngeneic Melanoma Mouse Models
- (2019) Sida Shen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases
- (2019) Margherita Brindisi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone deacetylase 6 promotes growth of glioblastoma through the MKK7/JNK/c‐Jun signaling pathway
- (2019) Ziyan Huang et al. JOURNAL OF NEUROCHEMISTRY
- Protective Effects of ACY-1215 Against Chemotherapy-Related Cognitive Impairment and Brain Damage in Mice
- (2019) Dongmei Wang et al. NEUROCHEMICAL RESEARCH
- Histone deacetylase 6 inhibitor tubastatin A attenuates angiotensin II-induced hypertension by preventing cystathionine γ-lyase protein degradation
- (2019) Zhexi Chi et al. PHARMACOLOGICAL RESEARCH
- Selective Inhibition of Histone Deacetylases 1/2/6 in Combination with Gemcitabine: A Promising Combination for Pancreatic Cancer Therapy
- (2019) Richard S. Laschanzky et al. Cancers
- Structural Basis of Catalysis and Inhibition of HDAC6 CD1, the Enigmatic Catalytic Domain of Histone Deacetylase 6
- (2019) Jeremy D. Osko et al. BIOCHEMISTRY
- Ricolinostat (ACY-1215) inhibits VEGF expression via PI3K/AKT pathway and promotes apoptosis in osteoarthritic osteoblasts
- (2019) Lei Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions
- (2019) Li Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of 2-quinolineacrylamides
- (2019) Shih-Wei Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Novel 2, 5-diketopiperazine derivatives as potent selective histone deacetylase 6 inhibitors: Rational design, synthesis and antiproliferative activity
- (2019) Xin Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Thiazole-containing compounds as therapeutic targets for cancer therapy
- (2019) Prabodh Chander Sharma et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)
- (2019) Sida Shen et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Development of Thiazolidinedione-Based HDAC6 Inhibitors to Overcome Methamphetamine Addiction
- (2019) Chiranjeev Sharma et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6
- (2019) Jeremy D. Osko et al. JOURNAL OF MEDICINAL CHEMISTRY
- Combination of a Histone Deacetylase 6 Inhibitor and a Somatostatin Receptor Agonist Synergistically Reduces Hepatorenal Cystogenesis in an Animal Model of Polycystic Liver Disease
- (2018) Maria Lorenzo Pisarello et al. AMERICAN JOURNAL OF PATHOLOGY
- The recent progress of isoxazole in medicinal chemistry
- (2018) Jie Zhu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of Novel benzofuroxan-based pyrrolidine hydroxamates as matrix metalloproteinase inhibitors with nitric oxide releasing activity
- (2018) Hao Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of histone deacetylase and DNA topoisomerase II-Targeted inhibitors
- (2018) Mitsuaki Yamashita et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Merging of ruxolitinib and vorinostat leads to highly potent inhibitors of JAK2 and histone deacetylase 6 (HDAC6)
- (2018) Lianbin Yao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Development of the first small molecule histone deacetylase 6 (HDAC6) degraders
- (2018) Ka Yang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- NK cells mediate synergistic antitumor effects of combined inhibition of HDAC6 and BET in a SCLC preclinical model
- (2018) Yan Liu et al. CANCER RESEARCH
- Blockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury
- (2018) Jinhua Tang et al. CLINICAL SCIENCE
- An Update on JAK Inhibitors
- (2018) Francesca Musumeci et al. CURRENT MEDICINAL CHEMISTRY
- 1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC
- (2018) Ritu Ojha et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and biological evaluation of tetrahydro- β -carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors
- (2018) Michel Leonhardt et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease
- (2018) Obdulia Rabal et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent advances in the discovery of potent and selective HDAC6 inhibitors
- (2018) Xiu-Xiu Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A novel HDAC6 inhibitor exerts an anti-cancer effect by triggering cell cycle arrest and apoptosis in gastric cancer
- (2018) Jing Dong et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The HDAC6 inhibitor ACY‑1215 enhances the anticancer activity of oxaliplatin in colorectal cancer cells
- (2018) Dong Hoon Lee et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Silence of HDAC6 suppressed esophageal squamous cell carcinoma proliferation and migration by disrupting chaperone function of HSP90
- (2018) Hua Tao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- (N-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma in Vitro and in Vivo
- (2018) Hsueh-Yun Lee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Marbostat-100 Defines a New Class of Potent and Selective Antiinflammatory and Antirheumatic Histone Deacetylase 6 Inhibitors
- (2018) Andreas Sellmer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Janus Kinase 2 (JAK2) and Histone Deacetylase (HDAC) Dual Inhibitors as a Novel Strategy for the Combinational Treatment of Leukemia and Invasive Fungal Infections
- (2018) Yahui Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Unfolded Protein Response: A Novel Therapeutic Target for Poor PrognosticBRAFMutant Colorectal Cancer
- (2018) Nicholas Forsythe et al. MOLECULAR CANCER THERAPEUTICS
- A452, an HDAC6-selective inhibitor, synergistically enhances the anticancer activity of chemotherapeutic agents in colorectal cancer cells
- (2018) Hye-Rim Won et al. MOLECULAR CARCINOGENESIS
- Multicomponent Synthesis and Binding Mode of Imidazo[1,2-a]pyridine-Capped Selective HDAC6 Inhibitors
- (2018) Marcel K. W. Mackwitz et al. ORGANIC LETTERS
- The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer’s disease model
- (2018) Sheng-Jun Fan et al. Cell Death & Disease
- Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies
- (2018) Margherita Brindisi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and synthesis of potent dual inhibitors of JAK2 and HDAC based on fusing the pharmacophores of XL019 and vorinostat
- (2018) Yu-yi Chu-Farseeva et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Evaluation of WO2017018805: 1,3,4-oxadiazole sulfamide derivatives as selective HDAC6 inhibitors
- (2018) Yuan-Yuan Liang et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Therapeutic potential of oxazole scaffold: a patent review (2006–2017)
- (2018) Ramandeep Kaur et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Protective Effect of Tubastatin A in CLP-Induced Lethal Sepsis
- (2018) Qiufang Deng et al. INFLAMMATION
- Histone deacetylase 6 in cancer
- (2018) Ting Li et al. Journal of Hematology & Oncology
- A highly HDAC6-selective inhibitor acts as a fluorescent probe
- (2018) Yi-Hsun Ho et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents
- (2018) Raffaella Cincinelli et al. PLoS One
- Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathways
- (2018) Jinlin Cao et al. Cell Death & Disease
- Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome
- (2018) Alan P. Kozikowski et al. ACS Chemical Neuroscience
- ACY-1215 exhibits anti-inflammatory and chondroprotective effects in human osteoarthritis chondrocytes via inhibition of STAT3 and NF-κB signaling pathways
- (2018) Chao Cheng et al. BIOMEDICINE & PHARMACOTHERAPY
- Design, synthesis, and biological evaluation of histone deacetylase inhibitors possessing glutathione peroxidase-like and antioxidant activities against Alzheimer’s disease
- (2018) Jinhui Hu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, synthesis, and bioactivity evaluation of novel Bcl-2/HDAC dual-target inhibitors for the treatment of multiple myeloma
- (2018) Ruolan Zhou et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structure, Functions and Selective Inhibitors of HDAC6
- (2018) Tao Liang et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Structural and energetic basis for the inhibitory selectivity of both catalytic domains of dimeric HDAC6
- (2018) Yudibeth Sixto-López et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Discovery of the First-in-Class Dual Histone Deacetylase–Proteasome Inhibitor
- (2018) Sanil Bhatia et al. JOURNAL OF MEDICINAL CHEMISTRY
- Quinazolin-2,4-dione-Based Hydroxamic Acids as Selective Histone Deacetylase-6 Inhibitors for Treatment of Non-Small Cell Lung Cancer
- (2018) Chao-Wu Yu et al. JOURNAL OF MEDICINAL CHEMISTRY
- HDAC6 inhibition protects cardiomyocytes against doxorubicin-induced acute damage by improving α-tubulin acetylation
- (2018) Rui Song et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Molecular Basis for the Selective Inhibition of Histone Deacetylase 6 by a Mercaptoacetamide Inhibitor
- (2018) Nicholas J. Porter et al. ACS Medicinal Chemistry Letters
- Tubacin, an HDAC6 Selective Inhibitor, Reduces the Replication of the Japanese Encephalitis Virus via the Decrease of Viral RNA Synthesis
- (2017) Chien-Yi Lu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combination of a novel HDAC6 inhibitor ACY-241 and anti-PD-L1 antibody enhances anti-tumor immunity and cytotoxicity in multiple myeloma
- (2017) A Ray et al. LEUKEMIA
- Targeted protein degradation by PROTACs
- (2017) Taavi K. Neklesa et al. PHARMACOLOGY & THERAPEUTICS
- Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors
- (2017) Nicholas J. Porter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synthesis and Pharmacological Evaluation of Selective Histone Deacetylase 6 Inhibitors in Melanoma Models
- (2017) Maurício T. Tavares et al. ACS Medicinal Chemistry Letters
- Design and Synthesis of Mercaptoacetamides as Potent, Selective, and Brain Permeable Histone Deacetylase 6 Inhibitors
- (2017) Wei Lv et al. ACS Medicinal Chemistry Letters
- Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non–Small Cell Lung Cancer
- (2017) Dennis O. Adeegbe et al. Cancer Discovery
- Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs
- (2017) Yuren Wang et al. Drug Design Development and Therapy
- HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer
- (2017) Teru Hideshima et al. Oncotarget
- Enhancement of pomalidomide anti-tumor response with ACY-241, a selective HDAC6 inhibitor
- (2017) Brian J. North et al. PLoS One
- Computer-aided identification of new histone deacetylase 6 selective inhibitor with anti-sepsis activity
- (2016) Jakyung Yoo et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Inside HDACs with more selective HDAC inhibitors
- (2016) Joëlle Roche et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Searching the conformational complexity and binding properties of HDAC6 through docking and molecular dynamic simulations
- (2016) Yudibeth Sixto-López et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Design and Synthesis of Janus Kinase 2 (JAK2) and Histone Deacetlyase (HDAC) Bispecific Inhibitors Based on Pacritinib and Evidence of Dual Pathway Inhibition in Hematological Cell Lines
- (2016) Eugene Guorong Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial
- (2016) Anas Younes et al. LANCET ONCOLOGY
- Histone deacetylase 6 structure and molecular basis of catalysis and inhibition
- (2016) Yang Hai et al. Nature Chemical Biology
- Structural insights into HDAC6 tubulin deacetylation and its selective inhibition
- (2016) Yasuyuki Miyake et al. Nature Chemical Biology
- Induced protein degradation: an emerging drug discovery paradigm
- (2016) Ashton C. Lai et al. NATURE REVIEWS DRUG DISCOVERY
- HPOB, an HDAC6 inhibitor, attenuates corticosterone-induced injury in rat adrenal pheochromocytoma PC12 cells by inhibiting mitochondrial GR translocation and the intrinsic apoptosis pathway
- (2016) Zong-yang Li et al. NEUROCHEMISTRY INTERNATIONAL
- Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot–Marie–Tooth Disease
- (2016) Veronick Benoy et al. Neurotherapeutics
- Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
- (2016) Andrew W. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- HDAC6 promotes cell proliferation and confers resistance to gefitinib in lung adenocarcinoma
- (2016) ZHIHAO WANG et al. ONCOLOGY REPORTS
- Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma
- (2016) Teru Hideshima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective HDAC inhibition by ACY-241 enhances the activity of paclitaxel in solid tumor models
- (2016) Pengyu Huang et al. Oncotarget
- Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors-What Some May Have Forgotten or Would Rather Forget?
- (2015) Sida Shen et al. ChemMedChem
- Identification of HDAC6-Selective Inhibitors of Low Cancer Cell Cytotoxicity
- (2015) Irina N. Gaisina et al. ChemMedChem
- A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma
- (2015) T. J. Galloway et al. CLINICAL CANCER RESEARCH
- Novel Bioactive Hybrid Compound Dual Targeting Estrogen Receptor and Histone Deacetylase for the Treatment of Breast Cancer
- (2015) Chu Tang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors
- (2015) Johanna Senger et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
- (2015) K.V. Woan et al. Molecular Oncology
- Creation of a histone deacetylase 6 inhibitor and its biological effects
- (2015) Ju-Hee Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone deacetylase 6 in health and disease
- (2015) Carole Seidel et al. Epigenomics
- Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids
- (2014) Kunal Nepali et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosis
- (2013) Daniel J. DeAngelo et al. BRITISH JOURNAL OF HAEMATOLOGY
- Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance
- (2013) Casey Cook et al. HUMAN MOLECULAR GENETICS
- Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
- (2013) Mercedes Lobera et al. Nature Chemical Biology
- Development of a histone deacetylase 6 inhibitor and its biological effects
- (2013) J.-H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SAR and in vivo evaluation of 4-aryl-2-aminoalkylpyrimidines as potent and selective Janus kinase 2 (JAK2) inhibitors
- (2012) Timothy Forsyth et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
- (2012) L. Santo et al. BLOOD
- The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment
- (2012) M. Stiborova et al. CURRENT MEDICINAL CHEMISTRY
- Structural Basis for Sirtuin Activity and Inhibition
- (2012) Hua Yuan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth
- (2012) Joel A. Bergman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Protein Aggregates Are Recruited to Aggresome by Histone Deacetylase 6 via Unanchored Ubiquitin C Termini
- (2011) Hui Ouyang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of the Macrocycle 11-(2-Pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a Potent Janus Kinase 2/Fms-Like Tyrosine Kinase-3 (JAK2/FLT3) Inhibitor for the Treatment of Myelofibrosis and Lymphoma
- (2011) Anthony D. William et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone deacetylases as regulators of inflammation and immunity
- (2011) Melanie R. Shakespear et al. TRENDS IN IMMUNOLOGY
- Structure and property based design, synthesis and biological evaluation of γ-lactam based HDAC inhibitors
- (2010) Eunhyun Choi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms
- (2010) A. Quintas-Cardama et al. BLOOD
- The Role of HDAC6 in Cancer
- (2010) Grace I. Aldana-Masangkay et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
- (2010) Kyle V. Butler et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Regulation of Cellular Metabolism by Protein Lysine Acetylation
- (2010) S. Zhao et al. SCIENCE
- MOLECULAR BIOLOGY: Dynamic DNA Methylation
- (2009) J. A. Law et al. SCIENCE
- Use of the Nitrile Oxide Cycloaddition (NOC) Reaction for Molecular Probe Generation: A New Class of Enzyme Selective Histone Deacetylase Inhibitors (HDACIs) Showing Picomolar Activity at HDAC6
- (2008) Alan P. Kozikowski et al. JOURNAL OF MEDICINAL CHEMISTRY
- Stepwise chromatin remodelling by a cascade of transcription initiation of non-coding RNAs
- (2008) Kouji Hirota et al. NATURE
- HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation
- (2008) R. B. Parmigiani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Traversing the coordination chemistry and chemical biology of hydroxamic acids
- (2007) Rachel Codd COORDINATION CHEMISTRY REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started